Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of HFT-290 (fentanyl citrate patch) in chronic pain
jRCT2080221311Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in chronic pain, sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on jRCT2080221311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221311.